592098

EGFL7, Parsatuzumab Biosimilar

Größe

£563.00

SKU:: 592098
Reinheit:: Purified by Protein A/G affinity chromatography. ≥95%. Endotoxin: ≤1EU/mg (LAL)
Lagerbedingungen:: -20°C
Hersteller:: United States Biological
Host:: Human
Immunogen:: Recombinant protein corresponding to human EGFL7, expressed in CHO cells.
Format:: Supplied as a liquid in PBS. No preservative added.
Weitere Details:: Parsatuzumab is under investigation in clinical trial NCT01366131, Study evaluating the safety and efficacy of MEGF0444A in combination with carboplatin, paclitaxel and Bevacizumab in patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy for advanced disease (NILE). Applications: Suitable for use in Functional Assays. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.